Advanced search
Publication Cover
Hematology Volume 3, 1998 - Issue 4
Submit an article Journal homepage
51
Views
2
CrossRef citations to date
0
Altmetric
Malignancy

Clinical Regression and Remission of Primary Refractory Angiocentric Lymphoma Following Autologous Tumour Peptide Antigen-charged Dendritic Cells After High-dose Chemotherapy and Autologous Stem Cell Rescue

David TaussigDepartment of Haematology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
,
Marc A. WilliamsDepartment of Haematology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
,
Claire WigginsDepartment of Haematology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
,
Roger M. FeakinsHistopathology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
,
Nicola McBrideDepartment of Haematology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
,
Adrian C. NewlandDepartment of Haematology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
&
Stephen M. KelseyDepartment of Haematology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, Whitechapel, LondonE1 2AD
 show all
Pages 277-289 | Received 27 Oct 1998, Published online: 13 Jul 2016

References

  • McGlave, P., Arthur, D., Haake, R. et al. (1987). Therapy of chronic myelogenous leukernia with allogeneic bone marrow transplantation. J. Clin. Oncol., 5, 1033–40.
  • Goldman, J. M., Gale, R. P., Horowitz, M. M. et al. (1988). Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann. Intern. Med., 108, 806–14.
  • Champlin, R. E. (1995). Separation of graft-versus-host-disease, graft-versus leukemia effect against chronic myelogenous leukemia. Exp. Hematol., 23, 1148–51.
  • Greco, G., Fruci, D., Accapezzato, D. et al. (1996). Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia, 10, 693–9.
  • ten Bosch, G. J. A., Joosten, A. M., Kessler, J. H. et al. (1996). Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunisation with a BCR-ABL breakpoint peptide. Blood, 88, 3522–7.
  • Bender, A., Sapp, M., Schuler, G. et al. (1996). Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J. Imm. Methods., 196, 121–35.
  • Romani, N., Reider, D., Heuer, M. et al. (1996). Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immun. Methods, 196, 137–51.
  • Caux, C., Vanbervliet, B., Massacrier, C. et al. (1996). CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF and TNF. J. Exp. Med., 184, 695–706.
  • Caux, C., Massacrier, C., Vanbervliet, B. et al. (1997). CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF and TNF II. Functional Analysis. Blood, 90, 1458–70.
  • Caux, C., Dezutter-Dambuyant, C., Scmitt, D. and Banchereau, J. (1992). GM-CSF and TNF co-operate in the generation of dendritic Langerhans cells. Nature, 360, 258–61.
  • Szabolcs, P., Moore, M. A. S. and Young, J. W. (1995). Expansion of immunostimulatory dendritic cells among myeloid progeny of human CD34+ bone marrow precursors culture with c-kit ligand, granulocyte-macrophage colony-stimulating factor and TNF. J Immunol., 154, 5851–61.
  • Cheever, M. A., Chen, W., Disis, M. L. et al. (1993). T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl. Ann. NY Acad. Sci., 690, 101–10.
  • Hsu, F. J., Benike, C., Fagnoli, F. et al. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med., 2, 52–9.
  • The International Lymphoma Study Group (1994). A revised European-American classification of lymphoid neoplasms. Blood, 84, 1361–92.
  • Nair, S. K., Boczkowski, D., Snyder, D. and Gilboa, E. (1997). Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur. J. Immunol., 27, 589–97.
  • Mills, W., Chopra, R., McMillan, A. et al. (1995). BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J. Clin. Oncol., 13, 588–95.
  • Williams, M. A., Kouroumoussis, I., Syndercombe-Court, D. et al. (1995). Administration of granulocyte-macrophage colony-stimulating factor after chemotherapy regulates the expression and secretion of monocyte tumor necrosis factor (TNF) and TNF receptors p. 55 and p.75. Blood, 86, 4234–42.
  • Loveland, B. E., Johns, T. G., Mackay, I. R. et al. (1992). Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Internat., 27, 501–10.
  • Drobyski, W. R. and Qazi, R. (1989). Spontaneous regression in non-Hodgkin's lymphoma: clinical and pathogenic considerations. Am. J. Hematol., 31, 138–41.
  • Nestle, F. O., Alijagic, S., Gilliet, M. et al. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med., 4, 328–32.
  • Lotze, M. T. (1997). Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer. Annals Surg., 226, 1–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.